A Novel Homozygous Mutation Causing Complete TYK2 Deficiency, with Severe Respiratory Viral Infections, EBV-Driven Lymphoma, and Jamestown Canyon Viral Encephalitis

被引:0
|
作者
Lucie Roussel
Anne Pham-Huy
Andrea C. Yu
Sunita Venkateswaran
Anna Perez
Guillaume Bourdel
Yichun Sun
Stephanya Tellez Villavicencio
Stéphane Bernier
Yongbiao Li
Makayla Kazimerczak-Brunet
Rolan Alattar
Marc-André Déry
Adam J. Shapiro
Justin Penner
Donald C. Vinh
机构
[1] Research Institute,Centre of Excellence for Genetic Research in Infection and Immunity
[2] McGill University Health Centre,Division of Infectious Diseases, Immunology and Allergy, Department of Pediatrics
[3] Children’s Hospital of Eastern Ontario,Division of Metabolics and Newborn Screening, Department of Pediatrics
[4] Children’s Hospital of Eastern Ontario,Division of Neurology, Department of Pediatrics
[5] Children’s Hospital of Eastern Ontario,Division of Respirology, Department of Pediatrics
[6] Montreal Children’s Hospital,Department of Pediatrics
[7] McGill University Health Centre,Division of Infectious Diseases, Department of Medicine
[8] Qikiqtani General Hospital,undefined
[9] McGill University Health Centre,undefined
关键词
Inborn error of immunity; TYK2; EBV lymphoma; Jamestown Canyon virus; viral encephalitis;
D O I
暂无
中图分类号
学科分类号
摘要
Autosomal recessive tyrosine kinase 2 (TYK2) deficiency is characterized by susceptibility to mycobacterial and viral infections. Here, we report a 4-year-old female with severe respiratory viral infections, EBV-driven Burkitt-like lymphoma, and infection with the neurotropic Jamestown Canyon virus. A novel, homozygous c.745C > T (p.R249*) variant was found in TYK2. The deleterious effects of the TYK2 lesion were confirmed by immunoblotting; by evaluating functional responses to IFN-α/β, IL-10, and IL-23; and by assessing its scaffolding effect on the cell surface expression of cytokine receptor subunits. The effects of the mutation could not be pharmacologically circumvented in vitro, suggesting that alternative modalities, such as hematopoietic stem cell transplantation or gene therapy, may be needed. We characterize the first patient from Canada with a novel homozygous mutation in TYK2.
引用
收藏
页码:2011 / 2021
页数:10
相关论文
共 1 条
  • [1] A Novel Homozygous Mutation Causing Complete TYK2 Deficiency, with Severe Respiratory Viral Infections, EBV-Driven Lymphoma, and Jamestown Canyon Viral Encephalitis
    Roussel, Lucie
    Pham-Huy, Anne
    Yu, Andrea C.
    Venkateswaran, Sunita
    Perez, Anna
    Bourdel, Guillaume
    Sun, Yichun
    Villavicencio, Stephanya Tellez
    Bernier, Stephane
    Li, Yongbiao
    Kazimerczak-Brunet, Makayla
    Alattar, Rolan
    Dery, Marc-Andre
    Shapiro, Adam J.
    Penner, Justin
    Vinh, Donald C.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (08) : 2011 - 2021